Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Why Inovio Stock Is Rising Today
12:30pm, Wednesday, 10'th Nov 2021
The company received a green light to begin a U.S. phase 3 study of its COVID-19 vaccine candidate.
Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim on Q3 2021 Results - Earnings Call Transcript
08:15pm, Tuesday, 09'th Nov 2021
Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim on Q3 2021 Results - Earnings Call Transcript
Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates
07:49pm, Tuesday, 09'th Nov 2021
Inovio (INO) delivered earnings and revenue surprises of 12.12% and 53.68%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Inovio Pharmaceuticals Sees A Bounce Off Support After COVID-19 Vaccine News
05:18pm, Tuesday, 09'th Nov 2021
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Tuesday after the FDA removed a hold on the company's late-stage COVID-19 vaccine trial in the U.S. Inovio Pharmaceuticals is tradin
Why Shares of Inovio Pharmaceuticals Rallied Today
03:39pm, Tuesday, 09'th Nov 2021
The FDA lifted its hold on the next step of its COVID-19 vaccine trial, although that doesn't mean much at this point.
INO Stock: The Covid-19 Vaccine News Helping Inovio Power Higher
01:16pm, Tuesday, 09'th Nov 2021
Inovio Pharmaceuticals (INO) stock is pushing higher on Tuesday after providing investors with an update on its Covid-19 vaccine. The post INO Stock: The Covid-19 Vaccine News Helping Inovio Power Hig
FDA Lifts Clinical Hold On Inovio's COVID-19 Vaccine Trial
10:51am, Tuesday, 09'th Nov 2021
The FDA has lifted a partial clinical hold on a late-stage trial of Inovio Pharmaceuticals Inc's (NASDAQ: INO) COVID-19 vaccine in the U.S. Inovio said it now has the authorization to proceed with
Inovio says the FDA lifted its 'hold' on the Phase 3 clinical trial for its COVID-19 shot
08:20am, Tuesday, 09'th Nov 2021
Shares of Inovio Pharmaceuticals Inc. INO, +0.75% gained 5.9% in premarket trading on Tuesday after the company said it can move forward with the Phase 3 clinical trial for its experimental COVID-19 s
AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio
07:41am, Monday, 01'st Nov 2021
MedImmune Limited, a unit of AstraZeneca Plc (NASDAQ: AZN), has notified Inovio Pharmaceuticals Inc (NASDAQ: INO) to terminate the DNA cancer vaccine development program agreement. Under the agr
INO Stock: Why The Price Increased This Past Week
07:06am, Friday, 15'th Oct 2021
The stock price of INOVIO (NASDAQ:INO) increased by over 7% this past week. This is why it happened.
Will Inovio Pharmaceuticals Stock See Higher Levels After A 6% Rise In A Week?
08:00am, Thursday, 14'th Oct 2021
The stock price of Inovio Pharmaceutic, a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, reached its 52-week high levels of around $19 in Februar
4 Growth Stocks With 187% to 434% Upside, According to Wall Street
05:51am, Wednesday, 13'th Oct 2021
Based on analysts' loftiest price targets, these companies could nearly triple or potentially quintuple investors' money over the next year.
INOVIO Announces Online Preprint Publication of Homologous Boosting Data for its COVID-19 DNA Vaccine Candidate, INO-4800
08:00am, Tuesday, 12'th Oct 2021
PLYMOUTH MEETING, Pa., Oct. 12, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infec
Is This The Turning Point for Inovio?
11:15am, Wednesday, 06'th Oct 2021
The biotech's streak of bad luck may be about to end, but risks remain.
Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Cantor 2021 Global Healthcare Conference (Transcript)
04:09pm, Thursday, 30'th Sep 2021
Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Cantor 2021 Global Healthcare Conference (Transcript)
